Shares of Biocon lost nearly 6% since it announced the stake saleBiocon Biologics has been valued at three times forward revenues, which some feel is below par
1 min read7 Jan 2020Syngene International promoter Biocon says it has sold 37,65,574 equity shares of Syngene amounting to 1.88% through open market sale
1 min read18 May 2018Biocon shares decline 5.53% to Rs626.80 per shares on BSE after the USFDA and a European regulator issued observations after inspection of its facility in Bengaluru
1 min read3 May 2018Three more approvals Biocon now expects this year in the US and Europe would expand its presence in the pioneering field of biosimilars
2 min read20 Mar 2018Biocon says USFDA has completed a pre-approval inspection of its manufacturing facility in Malaysia and issued a Form 483 with six observations
1 min read21 Feb 2018In other news, Hines will invest $23 million in Tata Housing Development's premium wellness-themed project Serein at Thane in Maharashtra
1 min read5 Dec 2017Biocon shares jump 16.33% to Rs519.50 as partner Mylan NV receives approval from the USFDA for its biosimilar for Roche's drug Herceptin
1 min read4 Dec 2017Biocon's Bengaluru unit, which had received observations relating to lapses in quality compliance earlier this year, has been cleared by the US FDA
2 min read20 Nov 2017Biocon has also filed applications for biosimilars trastuzumab and pegfilgrastim with the US Food and Drug Administration
2 min read7 Nov 2017USFDA issues complete response letter for Biocon and Mylan’s application for biosimilar pegfilgrastim seeking certain data before the product gets an approval
1 min read10 Oct 2017The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared